Main competitors
P/E (Y) Price to Book (Y) PEG (Y) EV / Sales (Y) EV / EBITDA (Y) EV / EBIT (Y) Dividend Yield (Y) Capi.($)
18.54x0.99x1.11x - - - - 5.02B
16.45x1.91x-2.39x3.57x9.64x10.55x0.62% 64.65B
28.14x4.2x2.14x5.7x16.49x21.05x0.56% 57.37B
33.12x6.68x0.64x11.21x21.14x25.02x-.--% 39.87B
-42.03x2.02x0.33x2.74x8.09x9.44x4.12% 33.6B
31.54x1.45x-1.07x3.44x10.36x12.19x-.--% 28.84B
15.6x3.04x6.46x2.75x8.5x8.35x-.--% 20.45B
-5.49x3.23x-0.29x7.31x-4.46x-4.23x-.--% 18.82B
49.25x4.9x0.26x5.24x37.64x34.29x-.--% 16.99B
25x3.5x0.02x5.17x13.94x19.4x-.--% 16.35B
-31.08x-5.39x0.73x14.66x-44.37x-46.14x-.--% 13.24B
-120.97x12305.08x2.53x12.02x-106.49x-120.82x-.--% 11.96B
60.51x25.14x0.56x37.94x51.32x52.69x0.15% 11.44B
16.12x - 0.17x3.46x12.68x15.2x-.--% 10.97B
38.61x - 2.77x - - - -.--% 8.87B
11.95x1.04x0.42x1.82x7.34x9.77x2.82% 6.41B
-127.62x - 8.46x - - - -.--% 6.27B
53.07x3.75x-0.68x - - - - 5.04B
12.34x1.15x-0.18x2.05x5.31x6.38x1.81% 5B
Average 4.37x 772.67x 1.16x 7.94x 3.14x 3.54x 0.59% 20.06B
Weighted average by Cap. 10.52x 417.86x 0.62x 6.73x 8.09x 9.43x 0.65%
Biopharmaceuticals